Psychoeducation Based on Acceptance and Commitment Therapy

May 7, 2025 updated by: Fatmanur ÖZCAN MİRCALI, Muğla Sıtkı Koçman University

Investigation of the Effect of Acceptance and Commitment Therapy-Based Psychoeducation on Rumination and Self-Compassion in Patients Diagnosed With Panic Disorder: Randomized Controlled Study

The aim of this study is to manage individual psychoeducation in acceptance and commitment therapy for problems with panic disorder and to evaluate the effect of this program on rumination and self-resilience.

Study Overview

Detailed Description

Panic disorder; palpitations, sweating, tachycardia, fear of death, depersonalization, derealization, fear of going crazy, etc. It is a psychiatric disorder with symptoms. The most commonly used psychotherapy method for panic disorder patients is cognitive behavioral therapies. Acceptance and Commitment Therapy is a psychotherapy method originating from cognitive behavioral therapy. Acceptance and Commitment Therapy helps individuals act in the direction of their values by allowing them to contact their painful experiences rather than trying to escape or try to get rid of their difficult experiences, thoughts, and feelings. Acceptance and Commitment Therapy supports psychological well-being by providing psychological flexibility in the person. Rumination is mental rumination, which is used to keep thoughts spinning in the mind repetitively after an event.Self-compassion is a concept used to mean understanding oneself despite one's mistakes. This study aims to create psychoeducation based on acceptance and commitment therapy for patients with panic disorder and to evaluate the effect of this program on rumination and self-compassion. Psychoeducation, an evidence-based practice, is very important for the nursing profession. Although nurses have a significant impact on psychoeducational practices, this role is ignored and not implemented adequately. In addition, since there is no research examining the concepts of rumination and self-compassion together in people with panic disorder, it is thought that our study will be useful in new research.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Mentese
      • Mugla, Mentese, Turkey, 48000
        • Muğla Sıtkı Koçman University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with Panic Disorder followed in Muğla Training and
  • Research Hospital Psychiatry Polyclinics,
  • Those between the ages of 18-65 who agree to participate in the research,
  • Those who were in a euthymic mood during the interview, according to physician control,
  • Those who speak Turkish,
  • Those who are literate,
  • Those who have a computer and internet access for the program to be conducted online if deemed necessary during the research process,
  • Not having undergone such training within the last year is within the scope of the inclusion criteria.

Exclusion Criteria:

  • Having a diagnosis of a psychiatric disease in addition to panic disorder,
  • Having an attack period during the training period,
  • Individuals with cognitive (diagnosed by a physician) and physical disability (hearing, speaking, etc.) are included in the exclusion criteria from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: psycoeducation
Psychoeducation based on acceptance and commitment therapy will be applied to the experimental group of 25 people. Pre-test, post-test and follow-up test will be applied.
Psychoeducation based on acceptance and commitment therapy will be applied to the experimental group.
Active Comparator: control
No intervention will be applied to the control group of 25 people. Pre-test, post-test and follow-up test will be applied.
No intervention will be applied to the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ruminative Thought Style Questionnaire
Time Frame: 7 week
The scale is a 7-point Likert type consisting of 20 items. 7 = Very good and 1 = Not at all, and participants are asked to score each item according to how much it reflects themselves. The internal consistency coefficient of the scale, Cronbach's alpha value, was found to be .907. In the item analysis, the item total score correlation was calculated and the total correlations of the items were found to be between 0.474 and 0.699.
7 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self Compassion Scale
Time Frame: 7 week
The original Self-Compassion Scale consists of 6 subscales containing 26 items. The scale is a 5-point Likert type and those who answer "almost never = 1 and almost always = 5" are asked to rate how often they move. The Turkish form of the self-compassion scale, unlike the original, consists of 24 items because the scale shows a unidimensional structure and at the same time, 2 items with item-total correlations below 30 were removed from the scale. The internal consistency coefficient of the scale was calculated as .89 and the test-retest correlation was calculated as .83.
7 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 30, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

November 21, 2024

First Submitted That Met QC Criteria

November 23, 2024

First Posted (Actual)

November 26, 2024

Study Record Updates

Last Update Posted (Actual)

May 8, 2025

Last Update Submitted That Met QC Criteria

May 7, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MuglaSKU-HEM-FOM-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Panic Disorder

Clinical Trials on Acceptance and Commitment Therapy-Based Psychoeducation

Subscribe